Daily intake of household-produced milk kefir on Salmonella Typhimurium infection in C57BL/6 mice: mortality, microbiota modulation, and immunological implications
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Mariana de Fátima Albuquerque Pereira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Health, Universidade Federal de Viçosa (UFV), Av. P.H. Rolfs, s/n., 36570-900, Viçosa, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Mice, Inbred C57BL, Salmonella typhimurium, Gastrointestinal Microbiome, Kefir. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: CNPq, CAPES, FAPEMIG.
Abstract (Originalsprache)
Aims
Salmonellosis, a major global cause of diarrheal diseases, significantly impacts the intestinal microbiome. Probiotic-rich beverages, such as kefir, are increasingly utilized as alternative health-promoting beverages associated with various microbiota benefits. This study investigated the repercussions of daily consumption of household-produced milk kefir on Salmonella enterica serovar Typhimurium infection in C57BL-6 mice. Methods and results Kefir consumption pre-infection reduced the presence of inflammatory cells in the colon and altered the cytokine profile by reducing IL-10 and increasing IFN-γ. Despite reducing intestinal inflammation, kefir intake did not yield a prompt response to an acute infection caused by the aggressive pathogen Salmonella. This contributed to increased mortality in the mice, evidenced by higher fecal Salmonella counts post-infection. Metabarcoding analysis demonstrated that the use of kefir before infection increases butyric acid by the higher abundance of Lachnospiraceae and Prevotellaceae families and genus in feces, coupled with an increase in Muribaculaceae family and Bacteroides genus among infected kefir-treated mice. While kefir hinted at microbiota alterations reducing enterobacteria (Helicobacter), decrease IL-10, and increased IFN-γ, butyric acid on pre-infection, the beverage potentially facilitated the systemic translocation of pathogens, intensifying the infection’s severity by altering the immune response.
Conclusions
The use of kefir in the dosage of 10% w/v (109 CFU), for acute infections with Salmonella Typhimurium, may not be enough to combat the infection and worsen the prognosis, leaving the intestine less inflamed, favoring the replication and translocation of the pathogen. These findings underscore the importance of prudently evaluating the widespread use of probiotics and probiotic-rich beverages, especially during acute infections, given their potential association with adverse effects during these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Health, Universidade Federal de Viçosa (UFV), Av. P.H. Rolfs, s/n., 36570-900, Viçosa, Minas Gerais, Brazil.
- Institute of Biological Science - Interunit Postgraduate Program in Bioinformatics, Universidade Federal de Minas Gerais (UFMG), Av. Antonio Carlos, 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil.
- Institute of Biological Sciences and Health, Universidade Federal de Viçosa - Campus Rio Paranaíba, Km 7, Rural area, 38810-000, Rio Paranaíba, Minas Gerais, Brazil.
- Department of Biochemistry and Molecular Biology, Universidade Federal de Viçosa, UFV. Av. P.H. Rolfs, s/n., 36570-900, Viçosa, Minas Gerais, Brazil.
- Department of General Biology, Universidade Federal de Viçosa (UFV), Av. P.H. Rolfs, s/n., 36570-900, Viçosa, Minas Gerais, Brazil.
- Department of Animal Biology, Universidade Federal de Viçosa (UFV), Av. P.H. Rolfs, s/n., 36570-900,Viçosa, Minas Gerais, Brazil.
ORCID-Profile: Mariana de Fátima Albuquerque Pereira, Leandro Licursi de Oliveira
Förderung
- CNPq
- CAPES
- FAPEMIG
Zitieren
APA
Albuquerque Pereira, M. F., Morais de Ávila, L. G., Dos Santos Cruz, B. C., Almeida, L. F., Macedo Simões, J., Campos Silva, B., Pereira Aguilar, A., de Oliveira, L. L., Vilela Gonçalves, R., Ribon, A. O. B., Mendes, T. A. O., & Gouveia Peluzio, M. D. C. (2024). Daily intake of household-produced milk kefir on Salmonella Typhimurium infection in C57BL/6 mice: mortality, microbiota modulation, and immunological implications. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae249
Vancouver
Albuquerque Pereira MF, Morais de Ávila LG, Dos Santos Cruz BC, Almeida LF, Macedo Simões J, Campos Silva B, et al. Daily intake of household-produced milk kefir on Salmonella Typhimurium infection in C57BL/6 mice: mortality, microbiota modulation, and immunological implications. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae249
BibTeX
@article{AlbuquerquePereira2024,
author = {Albuquerque Pereira, Mariana de Fátima and Morais de Ávila, Larissa Gabriela and Dos Santos Cruz, Bruna Cristina and Almeida, Lucas Filipe and Macedo Simões, Jordana and Campos Silva, Bruno and Pereira Aguilar, Ananda and de Oliveira, Leandro Licursi and Vilela Gonçalves, Reggiani and Ribon, Andréa de Oliveira Barros and Mendes, Tiago Antônio de Oliveira and Gouveia Peluzio, Maria do Carmo},
title = {Daily intake of household-produced milk kefir on Salmonella Typhimurium infection in C57BL/6 mice: mortality, microbiota modulation, and immunological implications},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae249}
}
EUVIMED